Abstract:OBJECTIVE To construct a new fusion anti-caries DNA vaccine pGJGAC/VAX encoding antigens of both S. mutans and S. sobrinus so as to enhance the protective effect of DNA vaccine against S. sobrinus infection. METHODS The CAT fragment of S. sobrinus OMZ176 gtf-I was amplified by semi-nest PCR and then inserted into the plasmid pGJA-P/VAX to construct the recombinant plasmid pGJGAC/VAX. The CHO cell was transfected and the expression of fusion protein detected using cellular immunohistochemistry and Western blot. Mice were immunized with pGJGAC/VAX and control plasmids via the intramuscular (i.m) or intranasal (i.n) routes. During the experiment, blood and saliva samples were collected at a 2-week interval for antibody assay by ELISA. Rats were orally challenged with S. mutans Ingbritt or S. sobrinus 6715 and then immunized i.n with pGJGAC/VAX, pGJA-P/VAX or pVAX1. The Keyes method was used to determine the caries activity. RESULTS (1) CAT sequence was identical to the related sequence of gtf-I (OMZ176) in GenBank. The recombinant plasmid pGJGAC/VAX encoded the genes of antigens of both S. mutans and S. sobrinus. The expressed protein could respond to specific anti-PAc, anti-GLU and anti-CAT antibodies respectively. (2) As for antibody reactions, mice in the experiment group had significantly higher levels of anti-PAc, anti-GLU and anti-CAT IgG antibodies than those in the pVAX1 group (P < 0.01). The peak responses of specific anti-CAT antibodies were observed at 8 weeks (GAC/i.m) and 10 weeks (GAC/i.n) and were approximately 62.13 microg/ml and 11.43 microg/ml respectively. The peak responses of specific anti-CAT IgA antibodies were seen at 8 weeks (GAC/i.m) and 10 weeks (GAC/i.n) and were approximately 0.67% and 0.80% respectively. (3) In the group infected with S. mutans or S. sobrinus, the pGJGAC/VAX-immunized rats showed significantly fewer E, Ds and Dm lesions than pVAX1-immunized rats (P < 0.05) and decreased Ds and Dm levels than pGJA-P/VAX-immunized rats (P < 0.05) while there was no obvious difference in E lesions between the two groups (P > 0.05). CONCLUSION A new fusion anti-caries DNA vaccine pGJGAC/VAX encoding antigens of both S. mutans and S. sobrinus is constructed successfully and expressed correctly in eukaryotic cells. It induces effective mucosal and systematic humoral responses so as to provide a better protection against S. sobrinus.

Preparation of Cationic Lipid Emulsion-encapsulated Anti-caries Vaccines and its Effect of Enhancing the Mucosal Immune

Study of Immune Response to the Combined DNA Vaccine and Protein Vaccine Against Caries in Mice.

[Efficacy of Immune Responses Induced by Anti-Caries DNA Vaccine-Loaded Bacterial Ghost in Mice].

Experimental Study of the Pilot-scale Products of Anti-caries DNA Vaccine pGJA-P/VAX in Mice

Immunization of Mice with Two Modified Anti-caries Plasmids Encoding Different Styles of S. sobrinus GTF Catalytic Region

Comparison of Immune Effect between the Recombinant Subunit rPAc Anti-caries Vaccine and Synthetic Peptides Vaccine

Enhanced Immunogenicity of an Anti-Caries Vaccine Encoding a Cell-Surface Protein Antigen of Streptococcus Mutans by Intranasal DNA Prime-Protein Boost Immunization.

Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine Through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes

Co-delivery of Ccl19 Gene Enhances Anti-Caries DNA Vaccine Pcia-P Immunogenicity in Mice by Increasing Dendritic Cell Migration to Secondary Lymphoid Tissues.

Immunogenic Characterization and Protection Against Streptococcus Mutans Infection Induced by Intranasal DNA Prime–protein Boost Immunization

Experiment Study of Anti-Carious Vaccine Inducing Long-Term Immune Responses and the Mechanism

Study on Immune Efficacy of Self-assembling Anti-caries Nanoparticle Vaccine

Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats.

[Protective Efficacy of a New Fusion Anti-Caries DNA Vaccine Encoding Antigens of Both Streptococcus Mutans and Streptococcus Sobrinus].

Flagellin Enhances Saliva IgA Response and Protection of Anti-Caries DNA Vaccine.

Targeted Fusion Anticaries DNA Vaccine Ptotected Gnotobiotic Hamsters from Caries

Mucosal and Systemic Immunization with Targeted Fusion Anti-Caries Dna Plasmid in Young Rats

Effects of targeted fusion anti-caries DNA vaccine pGJA-P/VAX in rats with caries.

Good Manufacturing Practices Production and Analysis of A Dna Vaccine Against Dental Caries

Protective Efficacy of A Targeted Anti-Caries Dna Plasmid Against Cariogenic Bacteria Infections